BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29075824)

  • 1. CT perfusion in normal liver and liver metastases from neuroendocrine tumors treated with targeted antivascular agents.
    Ng CS; Wei W; Duran C; Ghosh P; Anderson EF; Chandler AG; Yao JC
    Abdom Radiol (NY); 2018 Jul; 43(7):1661-1669. PubMed ID: 29075824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pre-enhancement set point on computed tomographic perfusion values in normal liver and metastases to the liver from neuroendocrine tumors.
    Ng CS; Chandler AG; Yao JC; Herron DH; Anderson EF; Charnsangavej C; Hobbs BP
    J Comput Assist Tomogr; 2014; 38(4):526-34. PubMed ID: 24651739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastases to the liver from neuroendocrine tumors: effect of duration of scan acquisition on CT perfusion values.
    Ng CS; Hobbs BP; Chandler AG; Anderson EF; Herron DH; Charnsangavej C; Yao J
    Radiology; 2013 Dec; 269(3):758-67. PubMed ID: 23824990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perfusion CT findings in patients with metastatic carcinoid tumors undergoing bevacizumab and interferon therapy.
    Ng CS; Charnsangavej C; Wei W; Yao JC
    AJR Am J Roentgenol; 2011 Mar; 196(3):569-76. PubMed ID: 21343498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of perfusion CT as a follow-up modality after transcatheter arterial chemoembolization: an experimental study in a rabbit model.
    Choi SH; Chung JW; Kim HC; Baek JH; Park CM; Jun S; Kim MU; Lee ES; Cho HR; Jae HJ; Lee W; Park JH
    Invest Radiol; 2010 Jul; 45(7):427-36. PubMed ID: 20440211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perfusion computed tomography as functional biomarker in randomized run-in study of bevacizumab and everolimus in well-differentiated neuroendocrine tumors.
    Yao JC; Phan AT; Hess K; Fogelman D; Jacobs C; Dagohoy C; Leary C; Xie K; Ng CS
    Pancreas; 2015 Mar; 44(2):190-7. PubMed ID: 25426617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver metastases from colorectal cancer treated with conventional and antiangiogenetic chemotherapy: evaluation with liver computed tomography perfusion and magnetic resonance diffusion-weighted imaging.
    Anzidei M; Napoli A; Zaccagna F; Cartocci G; Saba L; Menichini G; Cavallo Marincola B; Marotta E; Di Mare L; Catalano C; Passariello R
    J Comput Assist Tomogr; 2011; 35(6):690-6. PubMed ID: 22082538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring response to antiangiogenic treatment and predicting outcomes in advanced hepatocellular carcinoma using image biomarkers, CT perfusion, tumor density, and tumor size (RECIST).
    Jiang T; Kambadakone A; Kulkarni NM; Zhu AX; Sahani DV
    Invest Radiol; 2012 Jan; 47(1):11-7. PubMed ID: 21512396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma.
    Zhu AX; Holalkere NS; Muzikansky A; Horgan K; Sahani DV
    Oncologist; 2008 Feb; 13(2):120-5. PubMed ID: 18305056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT Perfusion Characteristics Identify Metastatic Sites in Liver.
    Wang Y; Hobbs BP; Ng CS
    Biomed Res Int; 2015; 2015():120749. PubMed ID: 26509144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfusion CT Changes in Liver Metastases from Pancreatic Neuroendocrine Tumors During Everolimus Treatment.
    D'Onofrio M; Cingarlini S; Ortolani S; Crosara S; DE Robertis R; Vallerio P; Grego E; Ciaravino V; Ruzzenente A; Landoni L; Scarpa A; Bassi C; Tortora G
    Anticancer Res; 2017 Mar; 37(3):1305-1311. PubMed ID: 28314296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dual vascular input functions on CT perfusion parameter values and reproducibility in liver tumors and normal liver.
    Ng CS; Chandler AG; Wei W; Anderson EF; Herron DH; Kurzrock R; Charnsangavej C
    J Comput Assist Tomogr; 2012; 36(4):388-93. PubMed ID: 22805665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiangiogenic and radiation therapy: early effects on in vivo computed tomography perfusion parameters in human colon cancer xenografts in mice.
    Ren Y; Fleischmann D; Foygel K; Molvin L; Lutz AM; Koong AC; Jeffrey RB; Tian L; Willmann JK
    Invest Radiol; 2012 Jan; 47(1):25-32. PubMed ID: 22178893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic Contrast-enhanced CT to Evaluate Early Response in Neuroendocrine Liver Metastases Treated With Everolimus and Radiation.
    Hudson JM; Singh S; Milot L; Patel C; Bailey C; Rodriguez-Freixinos V; Chan D; Hallet J; Law C; Myrehaug S
    Anticancer Res; 2022 Jul; 42(7):3523-3527. PubMed ID: 35790284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fractal analysis of CT perfusion images for evaluation of antiangiogenic treatment and survival in hepatocellular carcinoma.
    Hayano K; Lee SH; Yoshida H; Zhu AX; Sahani DV
    Acad Radiol; 2014 May; 21(5):654-60. PubMed ID: 24703479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of variability in breath-hold perfusion CT of hepatocellular carcinoma: a step toward clinical use.
    Petralia G; Summers P; Viotti S; Montefrancesco R; Raimondi S; Bellomi M
    Radiology; 2012 Nov; 265(2):448-56. PubMed ID: 22996748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of total liver perfusion imaging of CT for efficacy of transcatheter arterial chemoembolization combined with apatinib on rabbit VX2 liver tumors].
    Liu X; Deng L; Guo R; Liang Q; Liu S; Hu P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 May; 44(5):477-484. PubMed ID: 31303609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect on perfusion values of sampling interval of computed tomographic perfusion acquisitions in neuroendocrine liver metastases and normal liver.
    Ng CS; Hobbs BP; Wei W; Anderson EF; Herron DH; Yao JC; Chandler AG
    J Comput Assist Tomogr; 2015; 39(3):373-82. PubMed ID: 25626401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CT perfusion as an imaging biomarker in monitoring response to neoadjuvant bevacizumab and radiation in soft-tissue sarcomas: comparison with tumor morphology, circulating and tumor biomarkers, and gene expression.
    Kambadakone A; Yoon SS; Kim TM; Karl DL; Duda DG; DeLaney TF; Sahani DV
    AJR Am J Roentgenol; 2015 Jan; 204(1):W11-8. PubMed ID: 25539263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood supply of liver metastatic tumors observed by both CT arterial portography via superior mesenterica arterial and multi-slice spiral CT perfusion imaging].
    Shi GF; Wang Q; Li ZG; Wang SJ; DU Y; Wang YN
    Ai Zheng; 2007 Nov; 26(11):1257-62. PubMed ID: 17991329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.